Engineering therapeutic antibodies targeting G-protein–coupled receptors

por Jo, Migyeong, Jung, Sang Taek
Publicado 2016

Recent Achievements and Challenges in Prolonging the Serum Half-Lives of Therapeutic IgG Antibodies Through Fc Engineering

por Ko, Sanghwan, Jo, Migyeong, Jung, Sang Taek
Publicado 2021

Construction of an immunotoxin via site-specific conjugation of anti-Her2 IgG and engineered Pseudomonas exotoxin A

por Lee, Byeong Sung, Lee, Yumi, Park, Jisoo, Jeong, Bo Seok, Jo, Migyeong, Jung, Sang Taek, Yoo, Tae Hyeon
Publicado 2019

A human antibody against human endothelin receptor type A that exhibits antitumor potency

por Ju, Man-Seok, Ahn, Hye-Mi, Han, Seong-Gu, Ko, Sanghwan, Na, Jung-Hyun, Jo, Migyeong, Lim, Chung Su, Ko, Byoung Joon, Yu, Yeon Gyu, Lee, Won-Kyu, Kim, Youn-Jae, Jung, Sang Taek
Publicado 2021

An Fc variant with two mutations confers prolonged serum half-life and enhanced effector functions on IgG antibodies

por Ko, Sanghwan, Park, Sora, Sohn, Myung Ho, Jo, Migyeong, Ko, Byoung Joon, Na, Jung-Hyun, Yoo, Hojin, Jeong, Ae Lee, Ha, Kyungsoo, Woo, Ju Rang, Lim, Chungsu, Shin, Jung Hyu, Lee, Dohyun, Choi, So-Young, Jung, Sang Taek
Publicado 2022